Question 1

Am I eligible for this trial based on my current medications and health history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis clinical trial (NCT00085644). Contact the study team or your healthcare provider for specific answers.

Question 2

How does adalimumab compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis clinical trial (NCT00085644). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the possible side effects of adalimumab?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis clinical trial (NCT00085644). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to come in for visits during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis clinical trial (NCT00085644). Contact the study team or your healthcare provider for specific answers.

Question 5

What support will I receive for learning how to self-administer the injections?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis clinical trial (NCT00085644). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis clinical trial (NCT00085644). Contact the study team or your healthcare provider for specific answers.

What this study is about